Barrick Gold Corp. (NYSE: ABX) was raised to Outperform from Sector Perform at RBC Capital Markets.
Bioverativ Inc. (NASDAQ: BIVV) was started as Underperform with a $45 target price at Credit Suisse. The call is based on long-term competition concerns limiting its upside.
Blackhawk Network Holdings Inc. (NASDAQ: HAWK) was started as Buy at SunTrust Robinson Humphrey.
Ciena Corp. (NYSE: CIEN) was downgraded to Neutral from Buy with a $27 price target (versus a $23.74 close) at Goldman Sachs.
Clean Harbors Inc. (NYSE: CLH) was raised to Outperform from Perform with a $65 price target (versus a $55.74 close) at Oppenheimer. Despite major earnings misses in recent years, the firm sees macro tailwinds, growth opportunities and cost reductions generating EBITDA and free cash flow growth.
Entergy Corp. (NYSE: ETR) was raised to Outperform from Market Perform at Wells Fargo.
Gentherm Inc. (NASDAQ: THRM) was raised to Buy from Hold with target of $46 (versus a $37.45 close) at Argus.
Kite Pharma Inc. (NASDAQ: KITE) was reiterated as Buy and the price target was raised to $101 from $82 (versus an $83.56 close) at Jefferies. The call is after the NHS study set $649,000 as the upper limit for Axi-Cel pricing.
NCR Corp. (NYSE: NCR) was raised to Outperform from Perform and the price target was set at $51 (versus a $42.86 close) at Oppenheimer. A key driver here is an increased expectation in return of capital to shareholders.
Newmont Mining Co. (NYSE: NEM) was downgraded to Sector Perform from Outperform by RBC Capital Markets.
Rubicon Project Inc. (NYSE: RUBI) was downgraded to Hold from Buy and the price target was lowered to $7.25 from $9.00 (versus a $6.06 close) at Jefferies.
Salesforce.com Inc. (NYSE: CRM) was reiterated as Outperform with a $102 target at Wedbush. The firm noted that seasonality is increasing, but the market momentum and the competitive position remains favorable.
Texas Capital Bancshares Inc. (NASDAQ: TCBI) was downgraded to Outperform from Strong Buy and the price target was raised to $98 from $95 at Raymond James.
United Therapeutics Corp. (NASDAQ: UTHR) was started as Underperform with a target price of $120 at Credit Suisse. The firm feels that the shares seem overvalued versus short- and long-term risks.
Williams-Sonoma Inc. (NYSE: WSM) was downgraded to Market Perform from Outperform at William Blair. Wedbush maintained a Neutral rating and $48 target.
Wednesday’s top analyst calls were in Apple, Finisar, Intel, Netflix, Occidental Petroleum, Snap, Agilent Technologies and over a dozen more.